docetaxel anhydrous has been researched along with Chemotherapy-Induced Acral Erythema in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (84.21) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, L; Cui, X; Wang, D; Zhang, B; Zhang, X; Zhao, J | 1 |
| Chen, SC; Hsu, YH; Lin, YF; Shen, WC; Wang, CH | 1 |
| Alizadeh, N; Darjani, A; Mirpour, SH; Mohammadhoseini, M; Rafiei, E; Rafiei, R | 1 |
| Chiu, M; Cutler, L; Kim, G; Wang, H | 1 |
| Bernard-Marty, C; Dalenc, F; de Lafontan, B; Dulguerova, P; Guerrero, D; Guyonnaud, J; Levasseur, N; Levecq, JM; Massabeau, C; Ranc Royo, AL; Ribet, V; Rossi, AB; Salas, S; Sarda, C; Sibaud, V | 1 |
| Ayala, F; Cristaudo, A; Fabbrocini, G; Ionescu, MA; Panariello, L; Pellicano, M; Robert, G | 1 |
| Alcalde-Castro, J; Chávarri-Guerra, Y; León-Rodríguez, E; Orozco-Topete, R; Reyes-Gutiérrez, E; Soto-Perez-de-Celis, E | 1 |
| Ali, SK; Mwanzi, S; Nambafu, J; Orare, K | 1 |
| Carulli, A; Harris, CS; Wang, D | 1 |
| Ballardini, P; Borghi, A; Corazza, M; Minghetti, S; Virgili, A | 1 |
| Cataruozolo, PE; Cesari, R; Collier, M; Cortés, J; Curigliano, G; Elias, A; Goldhirsch, A; Huang, X; Kern, KA; Khosravan, R; Pivot, X | 1 |
| Bulut, G; Calka, O; Ozkol, HU | 1 |
| Abi Gerges, D; Buyse, M; Fung, H; Gelmon, KA; Gorbunova, V; Hegg, R; Ibrahim, A; Konecny, GE; Krasnozhon, D; Lipatov, O; Mackey, JR; Manikhas, A; Martin, M; McCarthy, N; Ramos-Vazquez, M; Semiglazov, V; Simms, L; Thireau, F; Verma, S; Webster, M | 1 |
| Kumagai, K; Miyaki, T; Nakamura, R; Okubo, Y; Tsujimura, H; Yamamoto, N | 1 |
| Chekerov, R; Darvin, ME; Eucker, J; Fuss, H; Jung, S; Kühnhardt, D; Lademann, J; Lee, BN; Patzelt, A; Sehouli, J; Yu, RX | 1 |
| Aogi, K; Ishiguro, H; Iwata, H; Kawaguchi, K; Kuroi, K; Masuda, N; Morita, S; Nakamura, S; Ohno, S; Toi, M | 1 |
| Bian, L; Cao, Y; Huang, HY; Jiang, ZF; Song, ST; Wang, T; Wu, SK; Zhang, SH | 1 |
| Bozionelou, V; Georgoulias, V; Kalykaki, A; Karachaliou, N; Kontopodis, E; Mavroudis, D; Papadimitraki, E; Syrigos, K; Tryfonidis, K; Ziras, N | 1 |
| Bian, L; Cao, Y; Huang, H; Jiang, Z; Song, S; Wang, T; Wu, S; Zhang, S | 1 |
1 review(s) available for docetaxel anhydrous and Chemotherapy-Induced Acral Erythema
| Article | Year |
|---|---|
Loss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Dermatoglyphics; Docetaxel; Female; Hand-Foot Syndrome; Humans | 2020 |
5 trial(s) available for docetaxel anhydrous and Chemotherapy-Induced Acral Erythema
| Article | Year |
|---|---|
Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Emollients; Epirubicin; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Hand-Foot Syndrome; Humans; Hydrotherapy; Hyperpigmentation; Lymphedema; Manual Lymphatic Drainage; Massage; Mastectomy; Middle Aged; Neoadjuvant Therapy; Pruritus; Quality of Life; Radiodermatitis; Radiotherapy, Adjuvant; Skin Care; Skin Diseases; Tamoxifen; Taxoids | 2018 |
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Gemcitabine; Hand-Foot Syndrome; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pyrroles; Sunitinib; Survival Rate; Taxoids; Thrombocytopenia; Triple Negative Breast Neoplasms | 2013 |
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Docetaxel; Double-Blind Method; Drug Administration Schedule; Fatigue; Febrile Neutropenia; Female; Hand-Foot Syndrome; Humans; Hypertension; Immunoglobulin G; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Ramucirumab; Stomatitis; Taxoids; Treatment Outcome | 2015 |
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Fluorouracil; Hand-Foot Syndrome; Humans; Middle Aged; Neoplasm Metastasis; Nervous System Diseases; Neutropenia; Remission Induction; Salvage Therapy; Taxoids; Treatment Outcome | 2012 |
Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2012 |
13 other study(ies) available for docetaxel anhydrous and Chemotherapy-Induced Acral Erythema
| Article | Year |
|---|---|
Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy.
Topics: Activities of Daily Living; Adult; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Cross-Sectional Studies; Docetaxel; Female; Hand-Foot Syndrome; Humans; Middle Aged; Surveys and Questionnaires; Taiwan | 2019 |
Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Hand-Foot Syndrome; Humans; Hyperpigmentation; Longitudinal Studies; Middle Aged; Mucositis; Nail Diseases; Prospective Studies; Review Literature as Topic; Skin Diseases | 2020 |
Fixed erythrodysesthesia plaques at sites of intravenous docetaxel infusion: an unusual cutaneous reaction to chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Hand-Foot Syndrome; Humans; Infusions, Intravenous; Paclitaxel | 2022 |
Topical non-occlusive polymers in hand-foot syndrome.
Topics: Administration, Cutaneous; Adult; Aged; Antineoplastic Agents; Capecitabine; Docetaxel; Female; Hand-Foot Syndrome; Humans; Italy; Male; Middle Aged; Ointments; Polymers; Prospective Studies; Quality of Life; Severity of Illness Index; Taxoids; Treatment Outcome | 2018 |
Chemotherapy-induced erythrodysesthesia of the breast.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Magnetic Resonance Imaging; Middle Aged | 2018 |
Pregabalin for Treatment of Docetaxel-Related Hand-Foot Syndrome.
Topics: Adenocarcinoma; Analgesics; Antineoplastic Agents; Docetaxel; Hand-Foot Syndrome; Humans; Male; Middle Aged; Pregabalin; Stomach Neoplasms; Treatment Outcome | 2019 |
Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature.
Topics: Adult; Docetaxel; Erythema; Hand-Foot Syndrome; Humans; Male; Taxoids | 2014 |
Hand-foot syndrome caused by docetaxel with no recurrence after switch to paclitaxel, a different taxane.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Female; Hand-Foot Syndrome; Humans; Middle Aged; Paclitaxel; Secondary Prevention; Taxoids | 2014 |
Chemotherapy-induced acral erythema with involvement of the face and neck: A case report.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Face; Female; Hand-Foot Syndrome; Humans; Neck; Pyridoxine; Skin; Taxoids; Trastuzumab; Vitamin B Complex; Young Adult | 2016 |
[Administration Order of FEC-DOC in Breast Cancer Adjuvant Chemotherapy Has an Effect on Toxicity].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Hand-Foot Syndrome; Humans; Middle Aged; Neoplasm Staging; Taxoids | 2015 |
Influence of Chemotherapy on the Antioxidant Status of Human Skin.
Topics: Adult; Aged; Antineoplastic Agents; Antioxidants; Carotenoids; Docetaxel; Doxorubicin; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Skin; Taxoids | 2016 |
Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey.
Topics: Acetamides; Breast Neoplasms; Chemotherapy, Adjuvant; Dexamethasone; Docetaxel; Erythema; Famotidine; Female; Glucocorticoids; Hand-Foot Syndrome; Histamine H2 Antagonists; Humans; Incidence; Logistic Models; Multivariate Analysis; Neoadjuvant Therapy; Piperidines; Pyridines; Ranitidine; Retrospective Studies; Steroids; Surveys and Questionnaires; Taxoids | 2011 |
[Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer].
Topics: Adult; Agranulocytosis; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Disease Progression; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Hand-Foot Syndrome; Humans; Leukopenia; Maintenance Chemotherapy; Middle Aged; Neoplasm Staging; Remission Induction; Retrospective Studies; Taxoids; Vinblastine; Vinorelbine | 2011 |